Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Deferasirox in Porphyria Cutanea Tarda
NCT00599326Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jan 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deferasirox in porphyria cutanea tarda (PCT), sponsored by UT Southwestern Medical Center. Started Jan 2008; status: completed.
02
Drugs
deferasirox
03
Conditions
porphyria cutanea tarda (PCT)
Beyond the preview
Go deeper on NCT00599326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599326.